The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 355:212 July 13, 2006 Number 2
NextNext

Optic Neuritis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Balcer, L. J.
-PubMed Citation
To the Editor: In her article on optic neuritis, Balcer (March 23 issue)1 points out that the patient with optic neuritis and multiple white-matter lesions, as seen on magnetic resonance imaging of the brain, is at increased risk for multiple sclerosis (which is correct) and that the treatment of such patients with interferon beta reduces or delays the "development of multiple sclerosis" (which is not correct). No treatment has been shown to reduce or prevent the development of multiple sclerosis, except with reference to a restricted window of time, which is clinically not a very meaningful way to think of . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.